section name header

Y-Site Injection Compatibility (1:1 Mixture)

Remimazolam besylate

(Mfr: PAI)(Conc: 2.5 mg/mL)

I

Dimenhydrinate

(Mfr: KLI)(Conc: 6.25 mg/mL)

Remarks:

Precipitation in 1 min at 20.7 to 21.7°C

Ref:

4109